Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

CLRB holding history

Cellectar Biosciences, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLRB overviewAll 13F holders of CLRBFull Q4 2025 holdings

Shares (Q4 2025)
89,120
Value
$262.9K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CLRB by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 202589,120$262.9K<0.1%+23,949+36.7%AddedHolders
Q3 202565,171$365.0K<0.1%+8,830+15.7%AddedHolders
Q2 202556,341$400.6K<0.1%−1,665,497−96.7%ReducedHolders
Q1 20251,721,838$542.4K<0.1%−5,163−0.3%ReducedHolders
Q4 20241,727,001$516.4K<0.1%+150.0%AddedHolders
Q3 20241,726,986$3.70M<0.1%+163,000+10.4%AddedHolders
Q2 20241,563,986$3.91M<0.1%+372,905+31.3%AddedHolders
Q1 20241,191,081$4.74M<0.1%+708,191+146.7%AddedHolders
Q4 2023482,890$1.34M<0.1%+307,006+174.6%AddedHolders
Q3 2023175,884$464.3K<0.1%+3,911+2.3%AddedHolders
Q2 2023171,973$335.3K<0.1%−3,510−2.0%ReducedHolders
Q1 2023175,483$250.9K<0.1%00.0%UnchangedHolders
Q4 2022175,483$300.1K<0.1%+106+0.1%AddedHolders
Q3 2022175,377$589.0K<0.1%00.0%UnchangedConverted for a 1-for-10 splitHolders
Q2 20221,753,800$708.0K<0.1%00.0%UnchangedHolders
Q1 20221,753,800$1.21M<0.1%−207,505−10.6%ReducedHolders
Q4 20211,961,305$1.30M<0.1%−2,905−0.1%ReducedHolders
Q3 20211,964,210$1.82M<0.1%+89,626+4.8%AddedHolders
Q2 20211,874,584$2.23M<0.1%+231,180+14.1%AddedHolders
Q1 20211,643,404$2.65M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.